Atossa Therapeutics
ATOS
#10636
Rank
HK$0.20 B
Marketcap
HK$20.75
Share price
-1.20%
Change (1 day)
250.40%
Change (1 year)

Market capitalization of Atossa Therapeutics (ATOS)

Market cap: HK$0.20 Billion

As of August 2026 Atossa Therapeutics has a market cap of HK$0.20 Billion. This makes Atossa Therapeutics the world's 10636th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Atossa Therapeutics from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$0.20 B-68.72%
2025HK$0.66 B-30.89%
2024HK$0.95 B11.26%
2023HK$0.86 B64.71%
2022HK$0.52 B-66.9%
2021HK$1.57 B351.14%
2020HK$0.35 B213.65%
2019HK$0.11 B139.08%
2018HK$46.69 M-28.58%
2017HK$65.38 M57.88%
2016HK$41.41 M-48.87%
2015HK$80.99 M-70.27%
2014HK$0.27 B-18.46%
2013HK$0.33 B-14.44%
2012HK$0.39 B

End of Day market cap according to different sources

On Aug 25th, 2026 the market cap of Atossa Therapeutics was reported to be:

HK$0.20 Billion
by Nasdaq info icon info icon
HK$0.20 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$5.118 T 2,470,984.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
HK$212.30 B 102,406.43%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$213.61 B 103,038.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
HK$22.13 B 10,588.09%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
HK$17.03 B 8,125.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
HK$0.28 B 38.48%๐Ÿ‡บ๐Ÿ‡ธ USA